We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has c... Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. Show more
As filed with the Securities and Exchange Commission on March 11, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
--12-310001750284falseFYCA0001750284us-gaap:ShareBasedPaymentArrangementEmployeeMemberolma:EquityIncentivePlan2020Memberus-gaap:PerformanceSharesMember2022-11-012022-11-300001750284olma:BioMedicalR...
false000175028400017502842024-03-112024-03-11 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...
Presented compelling clinical results for palazestrant both as a monotherapy and in combination with CDK4/6 inhibitors, ribociclib and palbociclib, in Q4 2023 Initiated OPERA-01 pivotal Phase 3...
Data published in Molecular Cancer Therapeutics describes the scientific background underlying the design, discovery and optimization of palazestrant (OP-1250)Pre-clinical results demonstrate that...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery...
="/Images/box-unchecked.jpg" alt="Checkbox not checked">2500003/20/2007Cash* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.5 | -4.23011844332 | 11.82 | 11.85 | 10.78 | 712149 | 11.22322343 | CS |
4 | -1.8 | -13.7195121951 | 13.12 | 15.32 | 10.65 | 1120680 | 12.17324261 | CS |
12 | -2.36 | -17.2514619883 | 13.68 | 16.775 | 10.65 | 831995 | 12.76834805 | CS |
26 | -1.76 | -13.4556574924 | 13.08 | 17.7911 | 9.96 | 798932 | 13.04642545 | CS |
52 | 7.88 | 229.069767442 | 3.44 | 17.7911 | 3 | 559959 | 11.71051136 | CS |
156 | -19.33 | -63.0668841762 | 30.65 | 36.7 | 2 | 420791 | 11.68593227 | CS |
260 | -35.68 | -75.914893617 | 47 | 60.27 | 2 | 393951 | 13.12052699 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions